Intravenous Immunoglobulins, Human + Placebos
Phase 3Withdrawn 0 watching 0 views this week📈 Rising
74
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Stiff-Person Syndrome
Conditions
Stiff-Person Syndrome
Trial Timeline
Dec 7, 2018 → Apr 26, 2019
NCT ID
NCT03749096About Intravenous Immunoglobulins, Human + Placebos
Intravenous Immunoglobulins, Human + Placebos is a phase 3 stage product being developed by Grifols for Stiff-Person Syndrome. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT03749096. Target conditions include Stiff-Person Syndrome.
Hype Score Breakdown
Clinical
27
Activity
18
Company
7
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03749096 | Phase 3 | Withdrawn |
Competing Products
1 competing product in Stiff-Person Syndrome
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Standard lymphodepletion regimen | Kyverna Therapeutics | Phase 2 | 44 |